FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...